Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Researchers Rebecca Kehm, PhD and Lauren Houghton, PhD, shed light on an emerging trend in early onset breast cancer, pointing to early adolescence as a key window that could provide needed answers.
A new advisory on how alcohol increases cancer risk addresses the growing body of evidence about alcohol’s harmful health impacts, including its direct link to cancer.
Since passage of the first COVID-19 relief bill in early March, Congress has provided roughly $3.6 billion in supplemental appropriations for the NIH for COVID-19 research and testing.
The Columbia COVID-19 Biobank has been up and running for just three weeks. The idea is to lend immediate support and invaluable resources to investigators working toward a cure for COVID-19.
The Flow Cytometry Shared Resource at the HICCC supports a wide variety of studies related to cancer biology, functional genomics and tumor immunology using the newest techniques.
The High Throughput Screening shared resource is equipped with state-of-the-art instrumentation, robotic automation, and software for running high-throughput screens using assay technologies.
The Molecular Pathology Shared Resource (MPSR) is a comprehensive service for researchers and scientists conducting cutting-edge experimental, basic science, and translational research at the HICCC.
In a span of just a few weeks, Kenneth Olive, PhD, has galvanized a team of volunteers—primarily students, postdocs, and staff scientists—to assist with the surging COVID-19 response across CUIMC.
CovidWatcher works as a crowd-sourcing research platform that surveys users—both healthy and potentially exposed to COVID-19—about their exposure to the virus, symptoms, and access to medical care.